Skip to main content

Peer Review reports

From: Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C

Original Submission
17 Aug 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Dec 2013 Reviewed Reviewer Report - Chao-Hung Hung
2 Jan 2014 Reviewed Reviewer Report - luigi adinolfi
6 Jan 2014 Reviewed Reviewer Report - lawrence serfaty
20 Apr 2014 Author responded Author comments - Juan Armendariz-Borunda
Resubmission - Version 3
20 Apr 2014 Submitted Manuscript version 3
21 Apr 2014 Author responded Author comments - Juan Armendariz-Borunda
Resubmission - Version 4
21 Apr 2014 Submitted Manuscript version 4
22 Apr 2014 Author responded Author comments - Juan Armendariz-Borunda
Resubmission - Version 5
22 Apr 2014 Submitted Manuscript version 5
22 Jun 2014 Reviewed Reviewer Report - lawrence serfaty
25 Jun 2014 Reviewed Reviewer Report - luigi adinolfi
Resubmission - Version 6
Submitted Manuscript version 6
11 Jul 2014 Author responded Author comments - Juan Armendariz-Borunda
Resubmission - Version 7
11 Jul 2014 Submitted Manuscript version 7
11 Jul 2014 Author responded Author comments - Juan Armendariz-Borunda
Resubmission - Version 8
11 Jul 2014 Submitted Manuscript version 8
11 Jul 2014 Author responded Author comments - Juan Armendariz-Borunda
Resubmission - Version 9
11 Jul 2014 Submitted Manuscript version 9
Publishing
14 Jul 2014 Editorially accepted
27 Jul 2014 Article published 10.1186/1471-230X-14-131

You can find further information about peer review here.

Back to article page